Biofocus DPI and the Institute for Oneworld Health have announced that they have expanded its 2006 collaboration in diarrheal disease drug discovery.
Under the expanded collaboration, Biofocus DPI is performing a high-throughput, cell-based functional screen to identify potential new drugs for the treatment of diarrheal diseases.
The 'hits' identified in this screen will be confirmed through a series of activity assays developed by Biofocus DPI specifically for this drug target.
In 2006, Biofocus DPI and the Institute for Oneworld Health initiated a collaboration to develop new drugs against childhood diarrheal disease in developing countries.
During this initial collaboration, cell-based functional assays have been developed by Biofocus DPI to find small molecule compounds with potential activity against a specific diarrheal disease target.
